Asia Pacific Radiopharmaceuticals Market (And Segment Forecasts 2024 - 2030) Size, Share & Trends Analysis Report By Product (Diagnostics, Therapeutics), By Type (Catheter, Doppler OCT, Handheld, Tabletop), By Application, By End Use, By Country
- Report Summary
- Table of Contents
- Segmentation
- Methodology
- Download FREE Sample
-
Download Sample Report
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Asia Pacific Radiopharmaceuticals Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Asia Pacific Radiopharmaceuticals Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Asia Pacific Radiopharmaceuticals Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Asia Pacific Radiopharmaceuticals Market: Solution Movement Analysis, 2018 & 2030 (USD Million)
4.3. Diagnostics
4.3.1. Diagnostic Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.2. SPECT
4.3.2.1. SPECT Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.3.3. PET
4.3.3.1. PET Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Therapeutics
4.4.1. Therapeutics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.2. Alpha Emitters
4.4.2.1. Alpha Emitters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.3. Beta Emitters
4.4.3.1. Beta Emitters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4.4. Brachytherapy
4.4.4.1. Brachytherapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Asia Pacific Radiopharmaceuticals Market: Application Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Asia Pacific Radiopharmaceuticals Market: Application Movement Analysis, 2018 & 2030 (USD Million)
5.3. Cardiology
5.3.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Neurology
5.4.1. Neurology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Oncology
5.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Thyroid
5.6.1. Thyroid Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Lymphona
5.7.1. Lymphona Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Bone Metastasis
5.8.1. Bone Metastasis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.9. Endocrine Tumor
5.9.1. Endocrine Tumor Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.10. Pulmonary Scans
5.10.1. Pulmonary Scans Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.11. Urology
5.11.1. Urology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.12. Others
5.12.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Asia Pacific Radiopharmaceuticals Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Asia Pacific Radiopharmaceuticals Market: End Use Movement Analysis, 2018 & 2030 (USD Million)
6.3. Hospitals
6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Diagnostic Centers
6.4.1. Ambulatory Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Asia Pacific Radiopharmaceuticals Market: Country Estimates & Trend Analysis
7.1. Asia Pacific Radiopharmaceuticals Market: Country Movement Analysis, 2018 & 2030 (USD Million)
7.2. China
7.2.1. China Radiopharmaceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Japan
7.3.1. Japan Radiopharmaceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. India
7.4.1. India Radiopharmaceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Australia
7.5.1. Australia Radiopharmaceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. South Korea
7.6.1. South Korea Radiopharmaceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Thailand
7.7.1. Thailand Radiopharmaceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.8. Singapore
7.8.1. Singapore Radiopharmaceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.9. New Zealand
7.9.1. New Zealand Radiopharmaceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.10. Philippines
7.10.1. Philippines Radiopharmaceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. Nordion Inc
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/Strategic Initiatives
8.4.2. Bracco
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/Strategic Initiatives
8.4.3. IRE - IRE ELiT - BE
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/Strategic Initiatives
8.4.4. NTP
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/Strategic Initiatives
8.4.5. ANSTO
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/Strategic Initiatives
8.4.6. ECZACIBAŞI-MONROL
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/Strategic Initiatives
8.4.7. Endo, Inc.
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/Strategic Initiatives
8.4.8. Lantheus
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/Strategic Initiatives
8.4.9. Eckert & Ziegler
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/Strategic Initiatives
8.4.10. Mallinckrodt company
8.4.10.1. Participant’s Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Recent Developments/Strategic Initiatives
8.4.11. Cardinal Health
8.4.11.1. Participant’s Overview
8.4.11.2. Financial Performance
8.4.11.3. Product Benchmarking
8.4.11.4. Recent Developments/Strategic Initiatives
Get Free Sample Report
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
Trusted market insights - try a free sample
See how our reports are structured and why industry leaders rely on Grand View Research. Get a free sample or ask us to tailor this report to your needs.
